Price prediction of the targeted drug selinesol in 2025

Selinexor is a new type of targeted therapy used to treat multiple myeloma and certain types of lymphoma. With the continuous progress of clinical research, the scope of application of selinesol is expected to be further expanded in 2025. It is currently widely sold in China and has been included in Class B medical insurance drugs. However, patients who enjoy the medical insurance reimbursement policy need to meet specific indications, such as relapsed or refractory multiple myeloma.

In the market, the common specifications of selinesol are20mg packaging, which is divided into two forms: 12 tablets and 16 tablets. According to the current market conditions, the price of domestic original drugs is about RMB 20,000 per box, which is relatively acceptable to many patients.

However, considering the financial burden on patients, some patients may choose overseas generic drugs. For example, the price of a 32-piece package of generic drugs produced by a pharmaceutical factory in Laos is only over RMB 2,000. In comparison, the economic burden is significantly reduced. However, consumers need to pay attention to the quality of generic drugs and the difference in efficacy with the original drugs.

On the other hand, the US version of the original drug sold overseas is more expensive, and a box of 8 tablets may cost more than 100,000 yuan. This high price is mainly affected by multiple factors such as R&D costs, market demand, and exchange rate fluctuations. Therefore, although the efficacy of the original drug may be guaranteed, its high price still prohibits many patients.

Taken together, Seleniso's acceptance in the domestic market has gradually increased, and its medical insurance coverage policy has also provided certain financial support to patients. However, patients need to weigh the relationship between financial burden and treatment effectiveness when choosing drugs, especially when faced with drugs of different prices and sources.

Reference materials:https://www.selincro.com/